. Author manuscript; available in PMC: 2012 Oct 29.

Published in final edited form as: J Int Neuropsychol Soc. 2011 Oct 12;18(1):57–67. doi: 10.1017/S1355617711001391

Table 1b.

Sample clinical characteristics

	Age of onset		Duration		# meds		SzFreq		MTS	Febrile¹	HxSE²
	M	SD	M	SD	M	SD	M	SD	%	%	%
Left TLE	15.53	12.9	20.1	12.8	2.2	0.9	9.1	9.3	80.0	21.5	20.0
Right TLE	15.29	11.5	20.9	14.4	2.4	0.6	5.2	3.9	58.8	31.3	16.7
Group ANOVAs/chi square tests	t=.056		t=−.181		t=−.586		t=1.693		χ²=1.663	χ²=.368	χ²=.041
Group ANOVAs/chi square tests	p=.96		p=.86		p=.56		p=.10		p=.20	p=.54	p=.84

Only available for 14/15 L-TLE and 16/17 R-TLE patients.

Only available for 10/15 L-TLE and 12/17 R-TLE patients.